HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
501	20151 Cattaneo A, Capsoni S, Paoletti F Towards Non Invasive Nerve Growth Factor Therapies for Alzheimer's Disease JOURNAL OF ALZHEIMERS DISEASE. 2008; 15 (2): 255-283	2	16	23	250
502	20776 Cole SL, Vassar R BACE1 structure and function in health and Alzheimer's disease CURRENT ALZHEIMER RESEARCH. 2008 APR; 5 (2): 100-120	0	23	29	250
503	24088 Saft C, Kosinski CM, Landwehrmeyer GB Progress in Premanifest and Manifest Diagnostics in Huntington's Disease AKTUELLE NEUROLOGIE. 2009 DEC; 36 (10): 506-+	0	1	3	250
504	24460 Shorter J Emergence and natural selection of drug-resistant prions MOLECULAR BIOSYSTEMS. 2010; 6 (7): 1115-1130	1	1	36	250
505	2796 MACKAY B, ORDONEZ NG PATHOLOGICAL EVALUATION OF NEOPLASMS WITH UNKNOWN PRIMARY TUMOR SITE SEMINARS IN ONCOLOGY. 1993 JUN; 20 (3): 206-228	0	37	13	249
506	14959 Sergeant N, Delacourte A, Buee L Tau protein as a differential biomarker of tauopathies BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 179-197	52	72	136	249
507	17289 Phillips W, Michell AW, Barker RA Neurogenesis in diseases of the central nervous system STEM CELLS AND DEVELOPMENT. 2006 JUN; 15 (3): 359-379	1	6	17	249
508	18952 Gains MJ, LeBlanc AC Canadian Association of Neurosciences Review: Prion protein and prion diseases: The good and the bad CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES. 2007 MAY; 34 (2): 126-145	0	3	9	249
509	20729 Andres RH, Meyer M, Ducray AD, Widmer HR Restorative neuroscience: concepts and perspectives SWISS MEDICAL WEEKLY. 2008 MAR 22; 138 (11-12): 155-172	1	1	39	249
510	14753 Schmidt B, Braun HA, Narlawar R Drug development and PET-diagnostics for Alzheimer's disease CURRENT MEDICINAL CHEMISTRY. 2005; 12 (14): 1677-1695	2	17	32	248
#	Date / Author / Journal	LCS	GCS	LCR	CR
511	22722 Buckingham SD, Jones AK, Brown LA, Sattelle DB Nicotinic Acetylcholine Receptor Signalling: Roles in Alzheimer's Disease and Amyloid Neuroprotection PHARMACOLOGICAL REVIEWS. 2009 MAR; 61 (1): 39-61	0	18	35	248
512	25031 Barber SC, Shaw PJ Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target FREE RADICAL BIOLOGY AND MEDICINE. 2010 MAR 1; 48 (5): 629-641	6	12	45	248
513	5609 Morrison RS, Kinoshita Y, Xiang H, Johnson MD, Kuntz C, et al. Mechanisms of neuronal cell death MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS. 1998; 4 (3): 157-170	1	8	12	247
514	7222 Bodey B, Bodey B, Siegel SE, Kaiser HE Fas (APO-1, CD95) receptor expression and new options for immunotherapy in childhood medulloblastomas ANTICANCER RESEARCH. 1999 JUL-AUG; 19 (4B): 3293-3314	2	8	13	247
515	7708 Merrill JE, Scolding NJ Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 1999 DEC; 25 (6): 435-458	1	53	15	247
516	15328 Block F, Dihne M, Loos M Inflammation in areas of remote changes following focal brain lesion PROGRESS IN NEUROBIOLOGY. 2005 APR; 75 (5): 342-365	1	32	9	247
517	15794 Kanthasamy AG, Kitazawa M, Kanthasamy A, Anantharam V Dieldrin-induced neurotoxicity: Relevance to Parkinson's disease pathogenesis NEUROTOXICOLOGY. 2005 AUG; 26 (4): 701-719	3	40	50	247
518	19359 Cuenda A, Rousseau S P38 MAP-Kinases pathway regulation, function and role in human diseases BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. 2007 AUG; 1773 (8): 1358-1375	1	142	11	247
519	22976 Nelson PT, Smith CD, Abner EA, Schmitt FA, Scheff SW, et al. Human cerebral neuropathology of Type 2 diabetes mellitus BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 MAY; 1792 (5): 454-469	0	10	14	247
520	23121 Donato R, Sorci G, Riuzzi F, Arcuri C, Bianchi R, et al. S100B's double life: Intracellular regulator and extracellular signal BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. 2009 JUN; 1793 (6): 1008-1022	0	21	7	247
#	Date / Author / Journal	LCS	GCS	LCR	CR
521	26492 Hirokawa N, Niwa S, Tanaka Y Molecular Motors in Neurons: Transport Mechanisms and Roles in Brain Function, Development, and Disease NEURON. 2010 NOV 18; 68 (4): 610-638	0	0	17	247
522	8345 Bartus RT On neurodegenerative diseases, models, and treatment strategies: Lessons learned and lessons forgotten a generation following the cholinergic hypothesis EXPERIMENTAL NEUROLOGY. 2000 JUN; 163 (2): 495-529	31	274	3	246
523	8623 Siegel GJ, Chauhan NB Neurotrophic factors in Alzheimer's and Parkinson's disease brain BRAIN RESEARCH REVIEWS. 2000 SEP; 33 (2-3): 199-227	35	202	27	246
524	16426 Ray SK Currently evaluated calpain and caspase inhibitors for neuroprotection in experimental brain ischemia CURRENT MEDICINAL CHEMISTRY. 2006; 13 (28): 3425-3440	2	16	10	246
525	17770 Perez-Neri I, Ramirez-Bermudez J, Montes S, Rios C Possible mechanisms of neurodegeneration in schizophrenia NEUROCHEMICAL RESEARCH. 2006 OCT; 31 (10): 1279-1294	0	13	26	246
526	17935 Golde TE Disease modifying therapy for AD? JOURNAL OF NEUROCHEMISTRY. 2006 NOV; 99 (3): 689-707	13	57	70	246
527	22019 de Bont JM, Packer RJ, Michiels EM, den Boer ML, Pieters R Biological background of pediatric medulloblastoma and ependymoma: A review from a translational research perspective NEURO-ONCOLOGY. 2008 DEC; 10 (6): 1040-1060	3	14	49	246
528	23622 Manto M, Marmolino D Animal Models of Human Cerebellar Ataxias: a Cornerstone for the Therapies of the Twenty-First Century CEREBELLUM. 2009 SEP; 8 (3): 137-154	0	1	21	246
529	25085 Kovacs GG, Botond G, Budka H Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics ACTA NEUROPATHOLOGICA. 2010 APR; 119 (4): 389-408	4	4	186	246
530	25623 Zetzsche T, Rujescu D, Hardy J, Hampel H Advances and perspectives from genetic research: development of biological markers in Alzheimer's disease EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. 2010 JUL; 10 (5): 667-690	0	1	22	246
#	Date / Author / Journal	LCS	GCS	LCR	CR
531	6675 Foley P, Riederer P Pathogenesis and preclinical course of Parkinson's disease JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 1999; (56): 31-74	6	27	11	245
532	16259 Poletti A, Negri-Cesi P, Martini L Reflections on the diseases linked to mutations of the androgen receptor ENDOCRINE. 2005 DEC; 28 (3): 243-262	2	12	20	245
533	17803 Lee JA, Lupski JR Genomic rearrangements and gene copy-number alterations as a cause of nervous system disorders NEURON. 2006 OCT 5; 52 (1): 103-121	3	109	8	245
534	5592 Hellweg R, von Richthofen S, Anders D, Baethge C, Ropke S, et al. The time course of nerve growth factor content in different neuropsychiatric diseases - a unifying hypothesis JOURNAL OF NEURAL TRANSMISSION. 1998; 105 (8-9): 871-903	4	46	10	244
535	12643 Lidow MS Calcium signaling dysfunction in schizophrenia: a unifying approach BRAIN RESEARCH REVIEWS. 2003 SEP; 43 (1): 70-84	2	43	22	244
536	13158 Milton NGN Role of hydrogen peroxide in the aetiology of Alzheimer's disease - Implications for treatment DRUGS & AGING. 2004; 21 (2): 81-100	3	34	41	244
537	18802 Boyer P, Phillips JL, Rousseau FL, Ilivitsky S Hippocampal abnormalities and memory deficits: New evidence of a strong pathophysiological link in schizophrenia BRAIN RESEARCH REVIEWS. 2007 APR; 54 (1): 92-112	2	41	18	244
538	19538 Mamelak M Alzheimer's disease, oxidative stress and gammahydroxybutyrate NEUROBIOLOGY OF AGING. 2007 SEP; 28 (9): 1340-1360	2	23	29	244
539	22039 Keshavan MS, Tandon R, Boutros NN, Nasrallah HA Schizophrenia, "just the facts": What we know in 2008 Part 3: Neurobiology SCHIZOPHRENIA RESEARCH. 2008 DEC; 106 (2-3): 89-107	3	22	15	244
540	23282 Yacoubian TA, Standaert DG Targets for neuroprotection in Parkinson's disease BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 676-687	1	10	66	244
#	Date / Author / Journal	LCS	GCS	LCR	CR
541	24276 Rabinovici GD, Miller BL Frontotemporal Lobar Degeneration Epidemiology, Pathophysiology, Diagnosis and Management CNS DRUGS. 2010; 24 (5): 375-398	1	1	133	244
542	25664 van Blitterswijk M, Landers JE RNA processing pathways in amyotrophic lateral sclerosis NEUROGENETICS. 2010 JUL; 11 (3): 275-290	2	2	67	244
543	5501 Feldkamp MM, Lau N, Guha A Signal transduction pathways and their relevance in human astrocytomas JOURNAL OF NEURO-ONCOLOGY. 1997 DEC; 35 (3): 223-248	1	47	2	243
544	14545 Schenck JF, Zimmerman EA High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR IN BIOMEDICINE. 2004 NOV; 17 (7): 433-445	5	81	16	243
545	17589 Alsberg E, von Recum HA, Mahoney MJ Environmental cues to guide stem cell fate decision for tissue engineering applications EXPERT OPINION ON BIOLOGICAL THERAPY. 2006 SEP; 6 (9): 847-866	0	10	5	243
546	17875 Klafki HW, Staufenbiel M, Kornhuber J, Wiltfang J Therapeutic approaches to Alzheimer's disease BRAIN. 2006 NOV; 129: 2840-2855	19	76	69	243
547	18317 O'Neill MJ, Messenger MJ, Lakics V, Murray TK, Karran EH, et al. Neuroreplacement, growth factor, and small molecule neurotrophic approaches for treating Parkinson's disease PHARMACOLOGY OF NEUROGENESIS AND NEUROENHANCEMENT. 2007; 77: 179-+	1	5	48	243
548	23711 Chokroverty S Sleep and Neurodegenerative Diseases SEMINARS IN NEUROLOGY. 2009 SEP; 29 (4): 446-467	0	2	24	243
549	7893 Bartold PM, Walsh LJ, Narayanan S Molecular and cell biology of the gingiva PERIODONTOLOGY 2000. 2000; 24: 28-55	1	46	3	242
550	13695 Prentice DA Adult stem cells ISSUES IN LAW & MEDICINE. 2004 SPR; 19 (3): 265-294	0	3	13	242
#	Date / Author / Journal	LCS	GCS	LCR	CR
551	13987 Harrison PJ The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications PSYCHOPHARMACOLOGY. 2004 JUN; 174 (1): 151-162	31	170	73	242
552	4835 AbiDargham A, Laruelle M, Aghajanian GK, Charney D, Krystal J The role of serotonin in the pathophysiology and treatment of schizophrenia JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES. 1997 WIN; 9 (1): 1-17	3	115	4	241
553	6212 Choi JY, Morris JC, Hsu CY Aging and cerebrovascular disease NEUROLOGIC CLINICS. 1998 AUG; 16 (3): 687-+	2	15	15	241
554	10327 Chan SL, Furukawa K, Mattson MP Presenilins and APP in neuritic and synaptic plasticity - Implications for the pathogenesis of Alzheimer's disease NEUROMOLECULAR MEDICINE. 2002; 2 (2): 167-196	8	34	39	241
555	11521 Nemunaitis J, Edelman J Selectively replicating viral vectors CANCER GENE THERAPY. 2002 DEC; 9 (12): 987-1000	2	20	13	241
556	16607 Herzig MC, Van Nostrand WE, Jucker M Mechanism of cerebral beta-amyloid angiopathy: Murine and cellular models BRAIN PATHOLOGY. 2006 JAN; 16 (1): 40-54	12	41	27	241
557	18869 Gonzalez-Alegre P Therapeutic RNA interference for neurodegenerative diseases: From promise to progress PHARMACOLOGY & THERAPEUTICS. 2007 APR; 114 (1): 34-55	6	20	28	241
558	20556 Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, et al. Multi-target-directed ligands to combat neurodegenerative diseases JOURNAL OF MEDICINAL CHEMISTRY. 2008 FEB 14; 51 (3): 347-372	10	91	34	241
559	26153 Waerzeggers Y, Monfared P, Viel T, Winkeler A, Jacobs AH Mouse models in neurological disorders: Applications of non-invasive imaging BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 OCT; 1802 (10): 819-839	0	1	39	241
560	4147 Bachus SE, Kleinman JE The neuropathology of schizophrenia JOURNAL OF CLINICAL PSYCHIATRY. 1996; 57: 72-83	6	34	9	240
#	Date / Author / Journal	LCS	GCS	LCR	CR
561	6843 Mills J, Reiner PB Regulation of amyloid precursor protein cleavage JOURNAL OF NEUROCHEMISTRY. 1999 FEB; 72 (2): 443-460	28	158	31	240
562	12350 Davis S, Laroche S What can rodent models tell us about cognitive decline in Alzheimer's disease? MOLECULAR NEUROBIOLOGY. 2003 JUN; 27 (3): 249-276	5	11	46	240
563	14757 Churcher I, Beher D gamma-secretase as a therapeutic target for the treatment of Alzheimer's disease CURRENT PHARMACEUTICAL DESIGN. 2005; 11 (26): 3363-3382	6	44	25	240
564	18030 Scharfman HE, MacLusky NJ Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: Complexity of steroid hormone-growth factor interactions in the adult CNS FRONTIERS IN NEUROENDOCRINOLOGY. 2006 DEC; 27 (4): 415-435	0	25	5	240
565	23223 Malkus KA, Tsika E, Ischiropoulos H Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle MOLECULAR NEURODEGENERATION. 2009 JUN 5; 4: Art. No. 24	2	8	80	240
566	25310 Du H, Yan SSD Mitochondrial medicine for neurodegenerative diseases INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. 2010 MAY; 42 (5): 560-572	0	2	10	240
567	5423 Rossner S Cholinergic immunolesions by 192IGG-saporin - A useful tool to simulate pathogenic aspects of Alzheimer's disease INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE. 1997 NOV; 15 (7): 835-850	2	22	19	239
568	10215 Packer L, Obermuller-Jevic UC Vitamin E in disease prevention and therapy: Future perspectives ANTIOXIDANT VITAMINS C AND E. 2002; : 255-288	0	4	4	239
569	20372 Allain H, Bentue-Ferrer D, Akwa Y Disease-modifying drugs and Parkinson's disease PROGRESS IN NEUROBIOLOGY. 2008 JAN; 84 (1): 25-39	1	12	71	239
570	22131 Fradin C, Satsoura D, Andrews DW PUNCHING HOLES IN MEMBRANES: HOW OLIGOMERIC PORE-FORMING PROTEINS AND LIPIDS COOPERATE TO FORM AQUEOUS CHANNELS IN MEMBRANES BIOMEMBRANE FRONTIERS: NANOSTRUCTURES, MODELS AND THE DESIGN OF LIFE, VOL 2. 2009; 2: 223-262	0	0	18	239
#	Date / Author / Journal	LCS	GCS	LCR	CR
571	22805 Levy OA, Malagelada C, Greene LA Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps APOPTOSIS. 2009 APR; 14 (4): 478-500	7	28	94	239
572	23037 Lavdas AA, Matsas R Towards personalized cell-replacement therapies for brain repair PERSONALIZED MEDICINE. 2009 MAY; 6 (3): 293-313	0	0	6	239
573	24934 Marmolino D, Manto M Past, Present and Future Therapeutics for Cerebellar Ataxias CURRENT NEUROPHARMACOLOGY. 2010 MAR; 8 (1): 41-61	0	0	7	239
574	8333 Shibata N, Hirano A, Yamamoto T, Kato Y, Kobayashi M Superoxide dismutase-1 mutation-related neurotoxicity in familial amyotrophic lateral sclerosis AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS. 2000 JUN; 1 (3): 143-161	6	26	35	238
575	11677 Pradat PF, Mallet J Gene transfer into the central and peripheral nervous system: Applications for the treatment of neurodegenerative diseases and peripheral neuropathies BIOTECHNOLOGY & GENETIC ENGINEERING REVIEWS, VOL 20. 2003; 20: 49-76	0	1	18	238
576	16468 Fonteh AN, Harrington RJ, Huhmer AF, Biringer RG, Riggins JN, et al. Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods DISEASE MARKERS. 2006; 22 (1-2): 39-64	2	25	8	238
577	5561 Ho TW, McKhann GM, Griffin JW Human autoimmune neuropathies ANNUAL REVIEW OF NEUROSCIENCE. 1998; 21: 187-226	1	66	3	237
578	7823 Jellinger KA Cell death mechanisms in Parkinson's disease JOURNAL OF NEURAL TRANSMISSION. 2000; 107 (1): 1-29	34	145	44	237
579	11004 Fillit HM, Butler RN, O'Connell AW, Albert MS, Birren JE, et al. Achieving and maintaining cognitive vitality with aging MAYO CLINIC PROCEEDINGS. 2002 JUL; 77 (7): 681-696	2	77	11	237
580	20632 Kim WS, Weickert CS, Garner B Role of ATP-binding cassette transporters in brain lipid transport and neurological disease JOURNAL OF NEUROCHEMISTRY. 2008 MAR; 104 (5): 1145-1166	3	23	17	237
#	Date / Author / Journal	LCS	GCS	LCR	CR
581	25562 Evans CG, Chang L, Gestwicki JE Heat Shock Protein 70 (Hsp70) as an Emerging Drug Target JOURNAL OF MEDICINAL CHEMISTRY. 2010 JUN 24; 53 (12): 4585-4602	0	3	27	237
582	3838 NEILL D ALZHEIMERS-DISEASE - MALADAPTIVE SYNAPTOPLASTICITY HYPOTHESIS NEURODEGENERATION. 1995 JUN; 4 (2): 217-232	6	18	14	236
583	11525 Burton EA, Fink DJ, Glorioso JC Gene delivery using herpes simplex virus vectors DNA AND CELL BIOLOGY. 2002 DEC; 21 (12): 915-936	5	41	2	236
584	14679 de Vrij FMS, Fischer DF, van Leeuwen FW, Hol EM Protein quality control in Alzheimer's disease by the ubiquitin proteasome system PROGRESS IN NEUROBIOLOGY. 2004 DEC; 74 (5): 249-270	12	50	54	236
585	15275 Sarkar C, Deb P, Sharma MC Recent advances in embryonal tumours of the central nervous system CHILDS NERVOUS SYSTEM. 2005 APR; 21 (4): 272-293	1	8	52	236
586	17799 Small SA, Gandy S Sorting through the cell biology of Alzheimer's disease: Intracellular pathways to pathogenesis NEURON. 2006 OCT 5; 52 (1): 15-31	16	80	22	236
587	23281 Cook C, Petrucelli L A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 664-675	4	10	118	236
588	26154 Wisniewski T, Sigurdsson EM Murine models of Alzheimer's disease and their use in developing immunotherapies BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 OCT; 1802 (10): 847-859	2	3	82	236
589	8571 Lesort M, Tucholski J, Miller ML, Johnson GVW Tissue transglutaminase: a possible role in neurodegenerative diseases PROGRESS IN NEUROBIOLOGY. 2000 AUG; 61 (5): 439-463	10	100	24	235
590	12702 Dauer W, Przedborski S Parkinson's disease: Mechanisms and models NEURON. 2003 SEP 11; 39 (6): 889-909	243	861	66	235
#	Date / Author / Journal	LCS	GCS	LCR	CR
591	14742 Meredith SC Protein denaturation and aggregation - Cellular responses to denatured and aggregated proteins CELL INJURY: MECHANISMS, RESPONSES, AND REPAIR. 2005; 1066: 181-221	7	35	51	235
592	16442 Sankaranarayanan S Genetically modified mice models for Alzheimer's disease CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2006; 6 (6): 609-627	0	3	55	235
593	17918 Adlard PA, Bush AI Metals and Alzheimer's disease JOURNAL OF ALZHEIMERS DISEASE. 2006 NOV; 10 (2-3): 145-163	11	80	31	235
594	22749 Gendron TF, Petrucelli L The role of tau in neurodegeneration MOLECULAR NEURODEGENERATION. 2009 MAR 11; 4: Art. No. 13	20	24	159	235
595	23021 Bates KA, Verdile G, Li QX, Ames D, Hudson P, et al. Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests MOLECULAR PSYCHIATRY. 2009 MAY; 14 (5): 469-486	2	11	28	235
596	23283 Wijeyekoon R, Barker RA Cell replacement therapy for Parkinson's disease BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 688-702	1	5	58	235
597	25773 Noble W, Hanger DP, Gallo JM Transgenic Mouse Models of Tauopathy in Drug Discovery CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 AUG; 9 (4): 403-428	0	0	152	235
598	1829 HALEGOUA S, ARMSTRONG RC, KREMER NE DISSECTING THE MODE OF ACTION OF A NEURONAL GROWTH-FACTOR CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY. 1991; 165: 119-170	4	165	11	234
599	23244 Huang XY, Reynolds AD, Mosley RL, Gendelman HE CD 4+T cells in the pathobiology of neurodegenerative disorders JOURNAL OF NEUROIMMUNOLOGY. 2009 JUN 25; 211 (1-2): 3-15	0	4	29	234
600	26376 Singh S, Vrishni S, Singh BK, Rahman I, Kakkar P Nrf2-ARE stress response mechanism: A control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases FREE RADICAL RESEARCH. 2010 NOV; 44 (11): 1267-1288	0	0	11	234

Date / Author / Journal

LCS

GCS

LCR

501

20151 Cattaneo A, Capsoni S, Paoletti F

Towards Non Invasive Nerve Growth Factor Therapies for Alzheimer's Disease

JOURNAL OF ALZHEIMERS DISEASE. 2008; 15 (2): 255-283

250

502

20776 Cole SL, Vassar R

BACE1 structure and function in health and Alzheimer's disease

CURRENT ALZHEIMER RESEARCH. 2008 APR; 5 (2): 100-120

250

503

24088 Saft C, Kosinski CM, Landwehrmeyer GB

Progress in Premanifest and Manifest Diagnostics in Huntington's Disease

AKTUELLE NEUROLOGIE. 2009 DEC; 36 (10): 506-+

250

504

24460 Shorter J

Emergence and natural selection of drug-resistant prions

MOLECULAR BIOSYSTEMS. 2010; 6 (7): 1115-1130

250

505

2796 MACKAY B, ORDONEZ NG

PATHOLOGICAL EVALUATION OF NEOPLASMS WITH UNKNOWN PRIMARY TUMOR SITE

SEMINARS IN ONCOLOGY. 1993 JUN; 20 (3): 206-228

249

506

14959 Sergeant N, Delacourte A, Buee L

Tau protein as a differential biomarker of tauopathies

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 179-197

136

249

507

17289 Phillips W, Michell AW, Barker RA

Neurogenesis in diseases of the central nervous system

STEM CELLS AND DEVELOPMENT. 2006 JUN; 15 (3): 359-379

249

508

18952 Gains MJ, LeBlanc AC

Canadian Association of Neurosciences Review: Prion protein and prion diseases: The good and the bad

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES. 2007 MAY; 34 (2): 126-145

249

509

20729 Andres RH, Meyer M, Ducray AD, Widmer HR

Restorative neuroscience: concepts and perspectives

SWISS MEDICAL WEEKLY. 2008 MAR 22; 138 (11-12): 155-172

249

510

14753 Schmidt B, Braun HA, Narlawar R

Drug development and PET-diagnostics for Alzheimer's disease

CURRENT MEDICINAL CHEMISTRY. 2005; 12 (14): 1677-1695

248

Date / Author / Journal

LCS

GCS

LCR

511

22722 Buckingham SD, Jones AK, Brown LA, Sattelle DB

Nicotinic Acetylcholine Receptor Signalling: Roles in Alzheimer's Disease and Amyloid Neuroprotection

PHARMACOLOGICAL REVIEWS. 2009 MAR; 61 (1): 39-61

248

512

25031 Barber SC, Shaw PJ

Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target

FREE RADICAL BIOLOGY AND MEDICINE. 2010 MAR 1; 48 (5): 629-641

248

513

5609 Morrison RS, Kinoshita Y, Xiang H, Johnson MD, Kuntz C, et al.

Mechanisms of neuronal cell death

MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS. 1998; 4 (3): 157-170

247

514

7222 Bodey B, Bodey B, Siegel SE, Kaiser HE

Fas (APO-1, CD95) receptor expression and new options for immunotherapy in childhood medulloblastomas

ANTICANCER RESEARCH. 1999 JUL-AUG; 19 (4B): 3293-3314

247

515

7708 Merrill JE, Scolding NJ

Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 1999 DEC; 25 (6): 435-458

247

516

15328 Block F, Dihne M, Loos M

Inflammation in areas of remote changes following focal brain lesion

PROGRESS IN NEUROBIOLOGY. 2005 APR; 75 (5): 342-365

247

517

15794 Kanthasamy AG, Kitazawa M, Kanthasamy A, Anantharam V

Dieldrin-induced neurotoxicity: Relevance to Parkinson's disease pathogenesis

NEUROTOXICOLOGY. 2005 AUG; 26 (4): 701-719

247

518

19359 Cuenda A, Rousseau S

P38 MAP-Kinases pathway regulation, function and role in human diseases

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. 2007 AUG; 1773 (8): 1358-1375

142

247

519

22976 Nelson PT, Smith CD, Abner EA, Schmitt FA, Scheff SW, et al.

Human cerebral neuropathology of Type 2 diabetes mellitus

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 MAY; 1792 (5): 454-469

247

520

23121 Donato R, Sorci G, Riuzzi F, Arcuri C, Bianchi R, et al.

S100B's double life: Intracellular regulator and extracellular signal

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. 2009 JUN; 1793 (6): 1008-1022

247

Date / Author / Journal

LCS

GCS

LCR

521

26492 Hirokawa N, Niwa S, Tanaka Y

Molecular Motors in Neurons: Transport Mechanisms and Roles in Brain Function, Development, and Disease

NEURON. 2010 NOV 18; 68 (4): 610-638

247

522

8345 Bartus RT

On neurodegenerative diseases, models, and treatment strategies: Lessons learned and lessons forgotten a generation following the cholinergic hypothesis

EXPERIMENTAL NEUROLOGY. 2000 JUN; 163 (2): 495-529

274

246

523

8623 Siegel GJ, Chauhan NB

Neurotrophic factors in Alzheimer's and Parkinson's disease brain

BRAIN RESEARCH REVIEWS. 2000 SEP; 33 (2-3): 199-227

202

246

524

16426 Ray SK

Currently evaluated calpain and caspase inhibitors for neuroprotection in experimental brain ischemia

CURRENT MEDICINAL CHEMISTRY. 2006; 13 (28): 3425-3440

246

525

17770 Perez-Neri I, Ramirez-Bermudez J, Montes S, Rios C

Possible mechanisms of neurodegeneration in schizophrenia

NEUROCHEMICAL RESEARCH. 2006 OCT; 31 (10): 1279-1294

246

526

17935 Golde TE

Disease modifying therapy for AD?

JOURNAL OF NEUROCHEMISTRY. 2006 NOV; 99 (3): 689-707

246

527

22019 de Bont JM, Packer RJ, Michiels EM, den Boer ML, Pieters R

Biological background of pediatric medulloblastoma and ependymoma: A review from a translational research perspective

NEURO-ONCOLOGY. 2008 DEC; 10 (6): 1040-1060

246

528

23622 Manto M, Marmolino D

Animal Models of Human Cerebellar Ataxias: a Cornerstone for the Therapies of the Twenty-First Century

CEREBELLUM. 2009 SEP; 8 (3): 137-154

246

529

25085 Kovacs GG, Botond G, Budka H

Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics

ACTA NEUROPATHOLOGICA. 2010 APR; 119 (4): 389-408

186

246

530

25623 Zetzsche T, Rujescu D, Hardy J, Hampel H

Advances and perspectives from genetic research: development of biological markers in Alzheimer's disease

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. 2010 JUL; 10 (5): 667-690

246

Date / Author / Journal

LCS

GCS

LCR

531

6675 Foley P, Riederer P

Pathogenesis and preclinical course of Parkinson's disease

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 1999; (56): 31-74

245

532

16259 Poletti A, Negri-Cesi P, Martini L

Reflections on the diseases linked to mutations of the androgen receptor

ENDOCRINE. 2005 DEC; 28 (3): 243-262

245

533

17803 Lee JA, Lupski JR

Genomic rearrangements and gene copy-number alterations as a cause of nervous system disorders

NEURON. 2006 OCT 5; 52 (1): 103-121

109

245

534

5592 Hellweg R, von Richthofen S, Anders D, Baethge C, Ropke S, et al.

The time course of nerve growth factor content in different neuropsychiatric diseases - a unifying hypothesis

JOURNAL OF NEURAL TRANSMISSION. 1998; 105 (8-9): 871-903

244

535

12643 Lidow MS

Calcium signaling dysfunction in schizophrenia: a unifying approach

BRAIN RESEARCH REVIEWS. 2003 SEP; 43 (1): 70-84

244

536

13158 Milton NGN

Role of hydrogen peroxide in the aetiology of Alzheimer's disease - Implications for treatment

DRUGS & AGING. 2004; 21 (2): 81-100

244

537

18802 Boyer P, Phillips JL, Rousseau FL, Ilivitsky S

Hippocampal abnormalities and memory deficits: New evidence of a strong pathophysiological link in schizophrenia

BRAIN RESEARCH REVIEWS. 2007 APR; 54 (1): 92-112

244

538

19538 Mamelak M

Alzheimer's disease, oxidative stress and gammahydroxybutyrate

NEUROBIOLOGY OF AGING. 2007 SEP; 28 (9): 1340-1360

244

539

22039 Keshavan MS, Tandon R, Boutros NN, Nasrallah HA

Schizophrenia, "just the facts": What we know in 2008 Part 3: Neurobiology

SCHIZOPHRENIA RESEARCH. 2008 DEC; 106 (2-3): 89-107

244

540

23282 Yacoubian TA, Standaert DG

Targets for neuroprotection in Parkinson's disease

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 676-687

244

Date / Author / Journal

LCS

GCS

LCR

541

24276 Rabinovici GD, Miller BL

Frontotemporal Lobar Degeneration Epidemiology, Pathophysiology, Diagnosis and Management

CNS DRUGS. 2010; 24 (5): 375-398

133

244

542

25664 van Blitterswijk M, Landers JE

RNA processing pathways in amyotrophic lateral sclerosis

NEUROGENETICS. 2010 JUL; 11 (3): 275-290

244

543

5501 Feldkamp MM, Lau N, Guha A

Signal transduction pathways and their relevance in human astrocytomas

JOURNAL OF NEURO-ONCOLOGY. 1997 DEC; 35 (3): 223-248

243

544

14545 Schenck JF, Zimmerman EA

High-field magnetic resonance imaging of brain iron: birth of a biomarker?

NMR IN BIOMEDICINE. 2004 NOV; 17 (7): 433-445

243

545

17589 Alsberg E, von Recum HA, Mahoney MJ

Environmental cues to guide stem cell fate decision for tissue engineering applications

EXPERT OPINION ON BIOLOGICAL THERAPY. 2006 SEP; 6 (9): 847-866

243

546

17875 Klafki HW, Staufenbiel M, Kornhuber J, Wiltfang J

Therapeutic approaches to Alzheimer's disease

BRAIN. 2006 NOV; 129: 2840-2855

243

547

18317 O'Neill MJ, Messenger MJ, Lakics V, Murray TK, Karran EH, et al.

Neuroreplacement, growth factor, and small molecule neurotrophic approaches for treating Parkinson's disease

PHARMACOLOGY OF NEUROGENESIS AND NEUROENHANCEMENT. 2007; 77: 179-+

243

548

23711 Chokroverty S

Sleep and Neurodegenerative Diseases

SEMINARS IN NEUROLOGY. 2009 SEP; 29 (4): 446-467

243

549

7893 Bartold PM, Walsh LJ, Narayanan S

Molecular and cell biology of the gingiva

PERIODONTOLOGY 2000. 2000; 24: 28-55

242

550

13695 Prentice DA

Adult stem cells

ISSUES IN LAW & MEDICINE. 2004 SPR; 19 (3): 265-294

242

Date / Author / Journal

551

The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications

PSYCHOPHARMACOLOGY. 2004 JUN; 174 (1): 151-162

170

242

552

4835 AbiDargham A, Laruelle M, Aghajanian GK, Charney D, Krystal J

The role of serotonin in the pathophysiology and treatment of schizophrenia

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES. 1997 WIN; 9 (1): 1-17

115

241

553

6212 Choi JY, Morris JC, Hsu CY

Aging and cerebrovascular disease

NEUROLOGIC CLINICS. 1998 AUG; 16 (3): 687-+

241

554

10327 Chan SL, Furukawa K, Mattson MP

Presenilins and APP in neuritic and synaptic plasticity - Implications for the pathogenesis of Alzheimer's disease

NEUROMOLECULAR MEDICINE. 2002; 2 (2): 167-196

241

555

11521 Nemunaitis J, Edelman J

Selectively replicating viral vectors

CANCER GENE THERAPY. 2002 DEC; 9 (12): 987-1000

241

556

16607 Herzig MC, Van Nostrand WE, Jucker M

Mechanism of cerebral beta-amyloid angiopathy: Murine and cellular models

BRAIN PATHOLOGY. 2006 JAN; 16 (1): 40-54

241

557

18869 Gonzalez-Alegre P

Therapeutic RNA interference for neurodegenerative diseases: From promise to progress

PHARMACOLOGY & THERAPEUTICS. 2007 APR; 114 (1): 34-55

241

558

20556 Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, et al.

Multi-target-directed ligands to combat neurodegenerative diseases

JOURNAL OF MEDICINAL CHEMISTRY. 2008 FEB 14; 51 (3): 347-372

241

559

26153 Waerzeggers Y, Monfared P, Viel T, Winkeler A, Jacobs AH

Mouse models in neurological disorders: Applications of non-invasive imaging

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 OCT; 1802 (10): 819-839

241

560

4147 Bachus SE, Kleinman JE

The neuropathology of schizophrenia

JOURNAL OF CLINICAL PSYCHIATRY. 1996; 57: 72-83

240

Date / Author / Journal

LCS

GCS

LCR

561

6843 Mills J, Reiner PB

Regulation of amyloid precursor protein cleavage

JOURNAL OF NEUROCHEMISTRY. 1999 FEB; 72 (2): 443-460

158

240

562

12350 Davis S, Laroche S

What can rodent models tell us about cognitive decline in Alzheimer's disease?

MOLECULAR NEUROBIOLOGY. 2003 JUN; 27 (3): 249-276

240

563

14757 Churcher I, Beher D

gamma-secretase as a therapeutic target for the treatment of Alzheimer's disease

CURRENT PHARMACEUTICAL DESIGN. 2005; 11 (26): 3363-3382

240

564

18030 Scharfman HE, MacLusky NJ

Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: Complexity of steroid hormone-growth factor interactions in the adult CNS

FRONTIERS IN NEUROENDOCRINOLOGY. 2006 DEC; 27 (4): 415-435

240

565

23223 Malkus KA, Tsika E, Ischiropoulos H

Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle

MOLECULAR NEURODEGENERATION. 2009 JUN 5; 4: Art. No. 24

240

566

25310 Du H, Yan SSD

Mitochondrial medicine for neurodegenerative diseases

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. 2010 MAY; 42 (5): 560-572

240

567

5423 Rossner S

Cholinergic immunolesions by 192IGG-saporin - A useful tool to simulate pathogenic aspects of Alzheimer's disease

INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE. 1997 NOV; 15 (7): 835-850

239

568

10215 Packer L, Obermuller-Jevic UC

Vitamin E in disease prevention and therapy: Future perspectives

ANTIOXIDANT VITAMINS C AND E. 2002; : 255-288

239

569

20372 Allain H, Bentue-Ferrer D, Akwa Y

Disease-modifying drugs and Parkinson's disease

PROGRESS IN NEUROBIOLOGY. 2008 JAN; 84 (1): 25-39

239

570

22131 Fradin C, Satsoura D, Andrews DW

PUNCHING HOLES IN MEMBRANES: HOW OLIGOMERIC PORE-FORMING PROTEINS AND LIPIDS COOPERATE TO FORM AQUEOUS CHANNELS IN MEMBRANES

BIOMEMBRANE FRONTIERS: NANOSTRUCTURES, MODELS AND THE DESIGN OF LIFE, VOL 2. 2009; 2: 223-262

239

Date / Author / Journal

LCS

GCS

LCR

571

22805 Levy OA, Malagelada C, Greene LA

Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps

APOPTOSIS. 2009 APR; 14 (4): 478-500

239

572

23037 Lavdas AA, Matsas R

Towards personalized cell-replacement therapies for brain repair

PERSONALIZED MEDICINE. 2009 MAY; 6 (3): 293-313

239

573

24934 Marmolino D, Manto M

Past, Present and Future Therapeutics for Cerebellar Ataxias

CURRENT NEUROPHARMACOLOGY. 2010 MAR; 8 (1): 41-61

239

574

8333 Shibata N, Hirano A, Yamamoto T, Kato Y, Kobayashi M

Superoxide dismutase-1 mutation-related neurotoxicity in familial amyotrophic lateral sclerosis

AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS. 2000 JUN; 1 (3): 143-161

238

575

11677 Pradat PF, Mallet J

Gene transfer into the central and peripheral nervous system: Applications for the treatment of neurodegenerative diseases and peripheral neuropathies

BIOTECHNOLOGY & GENETIC ENGINEERING REVIEWS, VOL 20. 2003; 20: 49-76

238

576

16468 Fonteh AN, Harrington RJ, Huhmer AF, Biringer RG, Riggins JN, et al.

Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods

DISEASE MARKERS. 2006; 22 (1-2): 39-64

238

577

5561 Ho TW, McKhann GM, Griffin JW

Human autoimmune neuropathies

ANNUAL REVIEW OF NEUROSCIENCE. 1998; 21: 187-226

237

578

7823 Jellinger KA

Cell death mechanisms in Parkinson's disease

JOURNAL OF NEURAL TRANSMISSION. 2000; 107 (1): 1-29

145

237

579

11004 Fillit HM, Butler RN, O'Connell AW, Albert MS, Birren JE, et al.

Achieving and maintaining cognitive vitality with aging

MAYO CLINIC PROCEEDINGS. 2002 JUL; 77 (7): 681-696

237

580

20632 Kim WS, Weickert CS, Garner B

Role of ATP-binding cassette transporters in brain lipid transport and neurological disease

JOURNAL OF NEUROCHEMISTRY. 2008 MAR; 104 (5): 1145-1166

237

Date / Author / Journal

LCS

GCS

LCR

581

25562 Evans CG, Chang L, Gestwicki JE

Heat Shock Protein 70 (Hsp70) as an Emerging Drug Target

JOURNAL OF MEDICINAL CHEMISTRY. 2010 JUN 24; 53 (12): 4585-4602

237

582

3838 NEILL D

ALZHEIMERS-DISEASE - MALADAPTIVE SYNAPTOPLASTICITY HYPOTHESIS

NEURODEGENERATION. 1995 JUN; 4 (2): 217-232

236

583

11525 Burton EA, Fink DJ, Glorioso JC

Gene delivery using herpes simplex virus vectors

DNA AND CELL BIOLOGY. 2002 DEC; 21 (12): 915-936

236

584

14679 de Vrij FMS, Fischer DF, van Leeuwen FW, Hol EM

Protein quality control in Alzheimer's disease by the ubiquitin proteasome system

PROGRESS IN NEUROBIOLOGY. 2004 DEC; 74 (5): 249-270

236

585

15275 Sarkar C, Deb P, Sharma MC

Recent advances in embryonal tumours of the central nervous system

CHILDS NERVOUS SYSTEM. 2005 APR; 21 (4): 272-293

236

586

17799 Small SA, Gandy S

Sorting through the cell biology of Alzheimer's disease: Intracellular pathways to pathogenesis

NEURON. 2006 OCT 5; 52 (1): 15-31

236

587

23281 Cook C, Petrucelli L

A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 664-675

118

236

588

26154 Wisniewski T, Sigurdsson EM

Murine models of Alzheimer's disease and their use in developing immunotherapies

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 OCT; 1802 (10): 847-859

236

589

8571 Lesort M, Tucholski J, Miller ML, Johnson GVW

Tissue transglutaminase: a possible role in neurodegenerative diseases

PROGRESS IN NEUROBIOLOGY. 2000 AUG; 61 (5): 439-463

100

235

590

12702 Dauer W, Przedborski S

Parkinson's disease: Mechanisms and models

NEURON. 2003 SEP 11; 39 (6): 889-909

243

861

235

Date / Author / Journal

591

Protein denaturation and aggregation - Cellular responses to denatured and aggregated proteins

CELL INJURY: MECHANISMS, RESPONSES, AND REPAIR. 2005; 1066: 181-221

235

592

16442 Sankaranarayanan S

Genetically modified mice models for Alzheimer's disease

CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2006; 6 (6): 609-627

235

593

17918 Adlard PA, Bush AI

Metals and Alzheimer's disease

JOURNAL OF ALZHEIMERS DISEASE. 2006 NOV; 10 (2-3): 145-163

235

594

22749 Gendron TF, Petrucelli L

The role of tau in neurodegeneration

MOLECULAR NEURODEGENERATION. 2009 MAR 11; 4: Art. No. 13

159

235

595

23021 Bates KA, Verdile G, Li QX, Ames D, Hudson P, et al.

Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests

MOLECULAR PSYCHIATRY. 2009 MAY; 14 (5): 469-486

235

596

23283 Wijeyekoon R, Barker RA

Cell replacement therapy for Parkinson's disease

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 688-702

235

597

25773 Noble W, Hanger DP, Gallo JM

Transgenic Mouse Models of Tauopathy in Drug Discovery

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 AUG; 9 (4): 403-428

152

235

598

1829 HALEGOUA S, ARMSTRONG RC, KREMER NE

DISSECTING THE MODE OF ACTION OF A NEURONAL GROWTH-FACTOR

CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY. 1991; 165: 119-170

165

234

599

23244 Huang XY, Reynolds AD, Mosley RL, Gendelman HE

CD 4+T cells in the pathobiology of neurodegenerative disorders

JOURNAL OF NEUROIMMUNOLOGY. 2009 JUN 25; 211 (1-2): 3-15

234

600

26376 Singh S, Vrishni S, Singh BK, Rahman I, Kakkar P

Nrf2-ARE stress response mechanism: A control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases

FREE RADICAL RESEARCH. 2010 NOV; 44 (11): 1267-1288

234

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records